Klor-con and Jakafi drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Klor-con (potassium chloride) and Jakafi (ruxolitinib phosphate). Common drug interactions include night sweats among females and anaemia among males.
The phase IV clinical study analyzes what interactions people have when they take Klor-con and Jakafi. It is created by eHealthMe based on reports of 262 people who take the same drugs from the FDA, and is updated regularly.
What is Klor-con?
Klor-con has active ingredients of potassium chloride. It is often used in hypokalemia. eHealthMe is studying from 27,547 Klor-con users. Check the latest studies of Klor-con.
What is Jakafi?
Jakafi has active ingredients of ruxolitinib phosphate. It is often used in primary myelofibrosis. eHealthMe is studying from 56,530 Jakafi users. Check the latest studies of Jakafi.
eHealthMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
262 people who take Klor-con and Jakafi together, and have interactions are studied.
What are the common drug interactions of Klor-con and Jakafi, by gender? *
What are the common drug interactions of Klor-con and Jakafi, by age (0-1 to 60+)? *
What are the existing conditions these people have? *
* Approximation only. Some reports may have incomplete information.
Do you take Klor-con and Jakafi?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
Browse all drug interactions of Klor-con and Jakafi:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Klor-con:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Jakafi:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Klor-con and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Jakafi and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study uses data from the FDA. It is based on potassium chloride and ruxolitinib phosphate (the active ingredients of Klor-con and Jakafi, respectively), and Klor-con and Jakafi (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Drug interactions of Lescol and Simvastatin - 7 seconds ago
- Could Lantus Solostar cause Activities Of Daily Living Impaired? - 15 seconds ago
- Drug interactions of Azithromycin and Fentanyl Citrate - 16 seconds ago
- Could Hydroxyzine Hydrochloride cause Diarrhea? - 31 seconds ago
- Could Hydroxyzine Hydrochloride cause Stools - Watery? - 31 seconds ago
- Tramadol Hydrochloride vs. Endep, side effect and effectiveness comparison - 36 seconds ago
- Drug interactions of Vitamin C and Lescol - 37 seconds ago
- Could Trusopt cause Jaw Disorder? - 38 seconds ago
- Could Coq10 cause Vaginal Bleeding? - 42 seconds ago
- Drug interactions of Sinemet and Nuplazid - 46 seconds ago